Equities

Vitro Biopharma Inc

Vitro Biopharma Inc

Actions
  • Price (USD)--
  • Today's Change--
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Vitro Biopharma, Inc. is a biotechnology company targeting autoimmune diseases and inflammatory disorders, with an ancillary focus in the research services and cosmeceutical fields. The Company is focused on developing therapeutic products, its stem cell technology, patent portfolio and proprietary technology and cell lines for applications in autoimmune disorders and inflammatory disease processes and stem cell research. The Company is engaged in the development of cellular therapeutic candidates intended to address significant unmet medical needs. In the United States, the Company is authorized to conduct two clinical trials under two Food and Drug Administration (FDA) Investigational New Drug applications to assess the safety and efficacy of AlloRx Stem Cell therapy in PTHS and Long COVID. It is also engaged in various other activities, including providing research services and stem cell products, as well as cosmeceuticals, through its wholly owned subsidiary, namely InfiniVive MD.

  • Revenue in USD (TTM)2.11m
  • Net income in USD-10.44m
  • Incorporated1986
  • Employees10.00
  • Location
    Vitro Biopharma Inc3200 CHERRY CREEK DRIVE SOUTH, SUITE 410DENVER 80209United StatesUSA
  • Phone+1 (855) 848-7627
  • Fax+1 (720) 859-4110
  • Websitehttps://www.vitrobiopharma.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Organovo Holdings Inc73.00k-13.99m7.63m12.00--1.07--104.48-1.39-1.390.00690.46350.006--0.74113,650.00-115.47-54.25-136.97-58.4250.68---19,160.27-1,890.163.38--0.00---70.54-48.7815.00---11.87--
Cyclerion Therapeutics Inc0.00-10.47m7.94m1.00--0.8393-----4.261.270.003.490.00----0.00-103.82-72.70-150.23-86.96-------2,565.62----0.00---100.00--30.98------
Intelligent Bio Solutions Inc3.11m-10.16m7.99m13.00--0.78--2.57-39.72-39.722.312.410.25791.928.60239,366.90-84.45-71.59-156.10-144.3645.81---327.50-565.481.42--0.0592--147.58596.394.47------
Pulmatrix Inc11.39m-10.84m8.00m22.00--0.6009--0.7021-2.97-2.973.123.640.483--21.64517,818.20-45.97-46.91-52.76-58.12-----95.18-238.04----0.00--20.21116.6225.03--104.29--
TFF Pharmaceuticals Inc1.20m-19.39m8.01m19.00--1.28--6.66-7.95-7.950.46591.810.1043--3.5163,293.68-168.10-79.57-212.66-83.41-----1,612.04-8,687.66----0.00--48.01--33.13------
Correlate Energy Corp5.65m-34.51m8.02m19.00------1.42-0.8359-0.83590.1457-0.04611.50--11.12297,377.40-915.61-315.47-----6.4515.42-610.79-201.03---1.07----122.2046.12-78.54------
Cell MedX Corp0.00-142.49k8.03m0.00---------0.0021-0.00210.00-0.00280.00-------190.76-703.78------84.03---2,996.54---4.35-----100.00--71.22------
Vitro Biopharma Inc2.11m-10.44m8.05m10.00------3.82-2.35-2.350.4745-1.690.27651.7120.61210,873.00-136.91---1,046.98--83.48---495.08--0.1865-4.19-----46.45--31.01------
Nascent Biotech Inc0.00-1.92m8.08m-----------0.012-0.0120.00-0.0030.00-------1,256.81-708.50-----------589.83------------25.47------
Mustang Bio Inc0.00-32.06m8.27m80.00---------2.91-2.910.00-0.23840.00----0.00-170.53-70.02-727.24-79.98--------------------33.44---60.75--
Silexion Therapeutics Corp0.00-523.87k8.50m0.00--1.33-----0.1403-0.14030.000.65590.00-------3.13---3.77--------------0.00-------54.96------
Carmell Corp12.32k-15.97m8.60m9.00------698.09-1.53-1.440.0006-0.0656------1,368.89--------58.73---129,263.60--0.6901-----------75.70------
ABVC Biopharma Inc136.40k-11.37m8.64m16.00--1.01--63.36-1.78-1.780.01720.68820.0114--0.42138,525.00-99.79-103.38-197.79-231.54-24.1176.25-8,762.13-2,019.89---2.500.1873---84.2885.3935.97------
Soligenix Inc494.62k-7.04m8.71m13.00--1.70--17.61-9.58-9.580.61522.250.0418--8.7038,047.69-59.45-75.40-121.64-154.328.7522.83-1,423.81-620.02----0.4421---11.54-30.6755.50------
Data as of --. Currency figures normalised to Vitro Biopharma Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.